{"id":1378,"date":"2020-05-04T18:48:57","date_gmt":"2020-05-04T17:48:57","guid":{"rendered":"https:\/\/ppra.inserm.dev-mlcom.net\/ppra\/reseau-de-recherche-avec-les-pays-a-ressources-limitees\/"},"modified":"2025-04-16T11:25:36","modified_gmt":"2025-04-16T10:25:36","slug":"research-network-with-low-and-middle-income-countries","status":"publish","type":"page","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/","title":{"rendered":"Research network with low- and middle-income countries"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1378\" class=\"elementor elementor-1378 elementor-247\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-27cede68 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"27cede68\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7c7a3a0e\" data-id=\"7c7a3a0e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5b44dce8 elementor-widget elementor-widget-text-editor\" data-id=\"5b44dce8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>Two main objectives are envisaged. The first is to organize and coordinate a network to structure future calls for projects and federate forces for research on antibiotic resistance in countries with limited resources. This structuring and coordination is recommended in conjunction with local scientists. It is well known that these countries have different perceptions of antimicrobial resistance, and it seems crucial to develop approaches to preventing and controlling antimicrobial resistance that are accepted by local populations (an action that will converge with measure 13 of the AMR plan&#8217;s coordinated action). The other objective is to be able to react rapidly in the event of the emergence of new microbial resistance in countries with limited resources.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ca4dde0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ca4dde0\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-13d062c\" data-id=\"13d062c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div data-dce-background-color=\"#FFFFFF\" class=\"elementor-element elementor-element-b4821b8 elementor-widget elementor-widget-button\" data-id=\"b4821b8\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/projets-actions-soutenus\/action-3-reseau-avec-les-pays-a-ressources-limitees-du-ppr-antibioresistance-developpement-de-2-projets-de-recherche\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">See more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Two main objectives are envisaged. The first is to organize and coordinate a network to structure future calls for projects and federate forces for research on antibiotic resistance in countries with limited resources. This structuring and coordination is recommended in conjunction with local scientists. It is well known that these countries have different perceptions of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1146,"parent":1372,"menu_order":7,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Research network with low- and middle-income countries - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Research network with low- and middle-income countries - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Two main objectives are envisaged. The first is to organize and coordinate a network to structure future calls for projects and federate forces for research on antibiotic resistance in countries with limited resources. This structuring and coordination is recommended in conjunction with local scientists. It is well known that these countries have different perceptions of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-16T10:25:36+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/\",\"name\":\"Research network with low- and middle-income countries - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-reseaurecherche.svg\",\"datePublished\":\"2020-05-04T17:48:57+00:00\",\"dateModified\":\"2025-04-16T10:25:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-reseaurecherche.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-reseaurecherche.svg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Priority Research Programme on\u00a0Antibiotic\u00a0resistance\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Research network with low- and middle-income countries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Research network with low- and middle-income countries - French\u00a0National ANTIBIOTIC RESISTANCE Portal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/","og_locale":"en_GB","og_type":"article","og_title":"Research network with low- and middle-income countries - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Two main objectives are envisaged. The first is to organize and coordinate a network to structure future calls for projects and federate forces for research on antibiotic resistance in countries with limited resources. This structuring and coordination is recommended in conjunction with local scientists. It is well known that these countries have different perceptions of [&hellip;]","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_modified_time":"2025-04-16T10:25:36+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/","name":"Research network with low- and middle-income countries - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-reseaurecherche.svg","datePublished":"2020-05-04T17:48:57+00:00","dateModified":"2025-04-16T10:25:36+00:00","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-reseaurecherche.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-reseaurecherche.svg"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/research-network-with-low-and-middle-income-countries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Priority Research Programme on\u00a0Antibiotic\u00a0resistance","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/antibiotic-resistance-priority-research-programme\/"},{"@type":"ListItem","position":3,"name":"Research network with low- and middle-income countries"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}}]}},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/pages\/1378"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=1378"}],"version-history":[{"count":8,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/pages\/1378\/revisions"}],"predecessor-version":[{"id":30306,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/pages\/1378\/revisions\/30306"}],"up":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/pages\/1372"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/1146"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=1378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}